Physician profile
Greg F Rubinstein
NPI 1376548792
$4,848.29
in general payments reported to CMS, 2019-2025
27 companies · $659 in 2025
The $659 reported for 2025 was more than what 78% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $225 · 2021: $452 · 2022: $958 · 2023: $915 · 2024: $656 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,230.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,277.36 | 2019-2025 | Collagenase Santyl, Regranex, Oasis |
| Organogenesis INC. | $681.75 | 2019-2025 | Puraply, Apligraf |
| Tactile Systems Technology INC | $430.58 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Zimmer Biomet Holdings, INC. | $356.89 | 2019-2020 | |
| Abbvie INC. | $300.33 | 2022-2024 | Dalvance |
| Kerecis Limited | $235.94 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amgen INC. | $207.13 | 2025 | Krystexxa |
| Treace Medical Concepts, INC. | $195.49 | 2022-2025 | |
| Grt US Holding, INC. | $166.72 | 2022 | |
| Hydrofera LLC | $128.08 | 2024 | Hydrofera Blue |
| Paragon 28, INC. | $121.57 | 2022 | |
| Urgo Medical North America, LLC | $117.94 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $117.63 | 2021 | |
| Stability Biologics, LLC | $107.62 | 2023 | |
| Hartmann USA, INC. | $96.51 | 2021-2024 | Sorbalgon 4x8 5/Bx, Zetuvit Plus 10x10 P10 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $51.61 | 2022 | |
| Integra Lifesciences Corporation | $47.68 | 2019-2022 | |
| Biowound Solutions, INC. | $33.75 | 2025 | Bio-Connekt |
| Convatec INC. | $32.43 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $30.28 | 2024 | Nuzyra |
| Next Science LLC | $24.61 | 2023 | Surgx, Blastx, Xperience |
| Curonix LLC | $18.64 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cashflow Solutions, LLC | $16.48 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Averitas Pharma INC. | $15.92 | 2024 | Qutenza |
| Bioventus LLC | $14.25 | 2022 | |
| Merck Sharp & Dohme LLC | $11.77 | 2019 | |
| Polarityte, INC. | $9.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.